MDB Capital Holdings (MDBH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting will be held virtually on December 10, 2024, with shareholders voting on four key proposals, including director elections, executive compensation, frequency of say-on-pay votes, and auditor ratification.
Only shareholders of record as of October 11, 2024, are eligible to vote, with Class A and Class B shares voting together as a single class.
Voting can be conducted online, by phone, or by mail, and shareholders may change their vote up to the day before the meeting.
The board recommends voting in favor of all proposals, including a three-year frequency for say-on-pay votes.
Voting matters and shareholder proposals
Shareholders will vote on electing eight directors, a non-binding say-on-pay resolution, the frequency of future say-on-pay votes, and ratification of RBSM LLP as auditor.
The board recommends a three-year interval for future advisory votes on executive compensation.
Shareholder proposals for the 2025 meeting must be submitted by March 1, 2025, with specific advance notice requirements for nominations.
Board of directors and corporate governance
The board consists of eight members, with four classified as independent under Nasdaq rules.
The CEO also serves as chairman; a lead independent director is appointed to enhance governance.
As a controlled company, exemptions from certain Nasdaq governance requirements are utilized, but an independent audit committee is maintained.
Board diversity is reviewed annually, considering gender, race, and experience, though no formal diversity policy exists.
Directors are encouraged to attend annual meetings, and a code of business conduct and insider trading policy are in place.
Latest events from MDB Capital Holdings
- Public venture model delivers liquid, tax-advantaged access to high-growth companies.MDBH
Investor presentation16 Mar 2026 - IPO launches with LTIR, offering downside protection and incentives for long-term investors.MDBH
Status Update15 Jan 2026 - Invizyne IPO, deep tech pipeline, and investor growth drive expansion despite higher losses.MDBH
Q3 202412 Jan 2026 - eXoZymes IPO and deconsolidation clarify results as platform and investor base expand.MDBH
Q4 202426 Dec 2025 - Shareholders will vote on directors and auditor, with control held by Class B shares and strong governance oversight.MDBH
Proxy Filing2 Dec 2025 - Q2 2025 net loss rose to $8.25M as focus shifts to profitable IPOs and a PatentVest spin-off.MDBH
Q2 202523 Nov 2025 - Scaling launches and major equity deals position for upside as market recovery is expected.MDBH
Q3 202521 Nov 2025 - Q1 2025 saw strong financings, platform growth, and a volatile portfolio amid macro risks.MDBH
Q1 202512 Nov 2025 - Scaling curated public ventures, prioritizing leadership and innovation in small-cap IPOs.MDBH
LD Micro Main Event XIX Investor Conference21 Oct 2025